Economic news
Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
2025.02.05 10:16
Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
Source link
2025.02.05 10:16
Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
Source link